Seasonal Influenza Vaccines Market Global Trend, Demand, Growth Analysis and Industry Forecast 2018-2026
Influenza
is contagious respiratory disease that is caused by influenza viruses
and can lead to hospitalization and even death in certain severe
cases. Influenza virus infect the respiratory tract (nose, throat,
and lungs) in humans. Seasonal influenza detected year-round and the
virus is most common during the influenza season especially in fall
and winter months. Moreover, the exact timing and duration of
influenza season varies, however influenza activity often begins in
winter months. At various geographical regions, influenza infection
exist at a low level throughout the year, however its shows seasonal
increase typically during the winter months. A seasonal influenza flu
vaccine aids in reducing the risk of getting infected with seasonal
flu and prevent its spreading throughout the year.
Some
of the key players in the seasonal influenza vaccines market includes
Sanofi S.A., CSL Limited, GlaxoSmithKline Plc., and Medimmune,
LLC. Key players in the market are involved in strategic mergers and
acquisitions, to cater to increasing demand for these vaccines. For
instance, in August 2017, Sanofi Pasteur acquired Protein Sciences
Corporation, thus adding Flublok products to its portfolio — the
only FDA approved recombinant protein-based influenza vaccine. With
the acquisition, Sanofi expanded its influenza vaccine portfolio and
its presence in the global vaccines market.
Download
the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1604
The 2017–2018
recommendations by the Advisory Committee on Immunization Practices
(ACIP) mentions routine annual influenza vaccination for everyone
aged 6 months and older with either inactivated influenza vaccine
(IIV) or recombinant influenza vaccine (RIV). A high variability and
broad host specificity of influenza viruses are the major causes of
repeated influenza infections. Moreover, virus neutralizing
antibodies induced by various vaccines are strain specific, which
leads to vaccinations being updated each year. To tackle this issue,
various government and private research organizations are engaged in
developing novel vaccines to increase efficacy of these vaccines.
Seasonal
Influenza Vaccines Market – Drivers
Increasing
incidence of seasonal influenza infection in various geographies is
expected to be a major driving factor for growth of global seasonal
influenza vaccines market. Rising pandemic events of influenza virus
and their severity attributed to the genetic diversity of influenza
virus is also another factor aiding in growth of the market.
According to the World Health Organization (WHO), 2015, around 233
million outpatient visits, 5.2 million hospital admissions, and 7.4
million deaths are expected if a pandemic case were to occur,
globally. Also, the Centers for Medicare & Medicaid Services
(CMS) provides reimbursement covering 100% of the costs of one
seasonal influenza virus vaccinations per influenza season, and it
also covers the seasonal influenza virus vaccinations. Thus,
favorable reimbursement is also expected to positively affect
adoption rates of seasonal influenza vaccines, thus propelling the
market growth.
Moreover,
influenza flu vaccination enables to reduce the risk of
flu-associated hospitalization among adult and pediatric patients.
For instance, according to the Centers for Disease Control and
Prevention, 2015, flu vaccinations prevented around 1.9 million flu
illnesses, 966,000 flu-associated medical visits, and around 67,000
flu-associated hospitalizations, representing 6.5% lowering of
disease burden in the U.S.
Seasonal
Influenza Vaccines Market – Taxonomy
By
Vaccine Type
By
Virus Type
By
Age Group
By
End User
Hospitals
Seasonal
Influenza Vaccines Market – Regional Analysis
Geographically,
global seasonal influenza vaccines market is segmented into North
America, Latin America, Europe, Middle East, Asia Pacific, and
Africa. North America holds the dominant position in seasonal
influenza vaccines market, owing to increasing research and
development studies by key market players, to develop novel influenza
vaccines and increasing burden of seasonal influenza infection in the
region.
Click To
Read More On Seasonal
Influenza Vaccines Market
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment